Cargando…
Validation of claims-based indicators used to identify flare-ups in inflammatory bowel disease
BACKGROUND & AIMS: There are currently no validated claims-based indicators for identifying a worsening of disease in patients with inflammatory bowel disease (IBD). Therefore, we aimed to develop and validate indicators that identify flare-ups of IBD using data from Danish nationwide registries...
Autores principales: | Burisch, Johan, Zhang, He, Choong, Casey Kar-Chan, Nelson, David, Naegeli, April, Gibble, Theresa, Goetz, Iris, Egeberg, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020737/ https://www.ncbi.nlm.nih.gov/pubmed/33868458 http://dx.doi.org/10.1177/17562848211004841 |
Ejemplares similares
-
Identifying Measures of Suboptimal Healthcare Interaction (SOHI) to Develop a Claims-Based Model for Predicting Patients with Inflammatory Bowel Disease at Risk for SOHI
por: Korrer, Stephanie, et al.
Publicado: (2023) -
Venous thromboembolism prophylaxis in inflammatory bowel disease flare-ups
por: Kaddourah, Osama, et al.
Publicado: (2019) -
Is hypertension an extra‐intestinal manifestation of inflammatory bowel disease?
por: Burisch, Johan
Publicado: (2023) -
Identification of inadequate responders to advanced therapy among commercially-insured adult patients with Crohn’s disease and ulcerative colitis in the United States
por: Gibble, Theresa Hunter, et al.
Publicado: (2023) -
The role of latanoprost in an inflammatory bowel disease flare
por: Paul, Sonali, et al.
Publicado: (2014)